The spectrum of nephrocutaneous diseases and associations : Inflammatory and medication-related nephrocutaneous associations - 15/01/16

Doi : 10.1016/j.jaad.2015.05.042

Vanessa L. Pascoe, MD ^a,^b, Andrew Z. Fenves, MD ^a, Jay Wofford, MD ^c, J. Mark Jackson, MD ^d, Alan Menter, MD ^c, Alexandra Boer Kimball, MD, MPH ^a,^⁎
^a Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
^b Johns Hopkins University School of Medicine, Baltimore, Maryland
^c Baylor University Medical Center, Dallas, Texas
^d Division of Dermatology, University of Louisville, Louisville, Kentucky

^∗Correspondence to: Alexandra Boer Kimball, MD, MPH, Clinical Unit for Research Trials and Outcomes in Skin, Department of Dermatology, Massachusetts General Hospital, 50 Staniford St, Ste 240, Boston, MA 02114.Clinical Unit for Research Trials and Outcomes in SkinDepartment of DermatologyMassachusetts General Hospital50 Staniford St, Ste 240BostonMA 02114

Abstract

There are a significant number of dermatoses associated with renal abnormalities and disease, and dermatologists need to be keenly aware of their presence in order to avoid overlooking important skin conditions with potentially devastating renal complications. This review discusses important nephrocutaneous disease associations and recommendations for the appropriate urgency of referral to nephrology colleagues for diagnosis, surveillance, and early management of potential renal sequelae. Part II of this 2-part continuing medical education article addresses inflammatory and medication-related nephrocutaneous associations.

Le texte complet de cet article est disponible en PDF.

Key words : antihypertensive medication, autoimmune, dermatology, genetic, genodermatoses, immunosuppression, inflammatory, medication side effects, nephrocutaneous, nephrology, renal transplantation